Amphastar Pharmaceuticals, Inc. (AMPH)
21.51
-0.09
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
21.51
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Total Liabilities (Quarterly) : 975.61M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 975.61M |
| March 31, 2026 | 874.77M |
| December 31, 2025 | 888.89M |
| September 30, 2025 | 889.48M |
| June 30, 2025 | 857.85M |
| March 31, 2025 | 874.99M |
| December 31, 2024 | 891.92M |
| September 30, 2024 | 817.50M |
| June 30, 2024 | 778.18M |
| March 31, 2024 | 901.96M |
| December 31, 2023 | 873.49M |
| September 30, 2023 | 949.49M |
| June 30, 2023 | 789.03M |
| March 31, 2023 | 225.08M |
| December 31, 2022 | 213.33M |
| September 30, 2022 | 221.53M |
| June 30, 2022 | 224.41M |
| March 31, 2022 | 236.71M |
| December 31, 2021 | 226.01M |
| September 30, 2021 | 221.50M |
| June 30, 2021 | 198.52M |
| March 31, 2021 | 194.78M |
| December 31, 2020 | 182.51M |
| September 30, 2020 | 162.76M |
| June 30, 2020 | 157.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 149.46M |
| December 31, 2019 | 159.44M |
| September 30, 2019 | 151.98M |
| June 30, 2019 | 169.01M |
| March 31, 2019 | 164.45M |
| December 31, 2018 | 149.20M |
| September 30, 2018 | 139.37M |
| June 30, 2018 | 131.12M |
| March 31, 2018 | 122.68M |
| December 31, 2017 | 117.34M |
| September 30, 2017 | 107.11M |
| June 30, 2017 | 110.68M |
| March 31, 2017 | 110.05M |
| December 31, 2016 | 98.48M |
| September 30, 2016 | 100.38M |
| June 30, 2016 | 101.12M |
| March 31, 2016 | 98.42M |
| December 31, 2015 | 94.63M |
| September 30, 2015 | 111.24M |
| June 30, 2015 | 113.66M |
| March 31, 2015 | 117.22M |
| December 31, 2014 | 107.51M |
| September 30, 2014 | 118.01M |
| June 30, 2014 | 109.53M |
| March 31, 2014 | 93.57M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 396.88M |
| Liquidia Corp. | 326.80M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.744B |
| Shareholders Equity (Quarterly) | 768.16M |
| Debt to Equity Ratio | 0.8961 |
| Current Ratio | 2.397 |
| Net Debt Paydown Yield | -0.83% |